Advertisement
"We are pleased that the members of the Local 3, Service EmployeesInternational Union, CTW, have ratified this agreement as our employees areextremely important to Caraco's strategy and continued growth," said Daniel H.Movens, Caraco's Chief Executive Officer.
Advertisement
This press release should be read in conjunction with our Form 8-K, whichprovides more detailed information on the labor agreement.
Detroit-based Caraco Pharmaceutical Laboratories, Ltd., develops,manufactures, markets and distributes generic and private-labelpharmaceuticals to the nation's largest wholesalers, distributors, drugstorechains and managed care providers.
Safe Harbor: This news release contains forward-looking statements madepursuant to the safe-harbor provisions of the Private Securities LitigationReform Act of 1995. Such statements are based on management's currentexpectations and are subject to risks and uncertainties that could causeactual results to differ materially from those described in the forward-looking statements. These risks and uncertainties are contained in theCorporation's filings with the Securities and Exchange Commission, includingItem 1A to the Corporation's annual report on Form 10-K, and include, but arenot limited to: information of a preliminary nature that may be subject toadjustment, potentially not obtaining or delay in obtaining FDA approval fornew products, governmental restrictions on the sale of certain products,development by competitors of new or superior products or less expensiveproducts or new technology for the production of products, the entry into themarket of new competitors, market and customer acceptance and demand for newpharmaceutical products, availability of raw materials, timing and success ofproduct development and launches, dependence on few products generatingmajority of sales, product liability claims for which the Company may beinadequately insured, and other risks identified in this report and from timeto time in our periodic reports and registration statements. Theseforward-looking statements represent our judgment as of the date of thisreport. We disclaim, however, any intent or obligation to update ourforward-looking statements.
SOURCE Caraco Pharmaceutical Laboratories, Ltd.
